Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3 results about "Diagnostic model" patented technology

Nasopharyngeal carcinoma auxiliary diagnosis model construction and auxiliary diagnosis method and system

ActiveCN111653365AMedical simulationMedical imagesNasopharyngeal cancerTherapeutic effect
The invention discloses a nasopharyngeal carcinoma auxiliary diagnosis model construction and auxiliary diagnosis method and system, and relates to the technical field of medical data processing. Thenasopharyngeal carcinoma auxiliary diagnosis model construction method comprises the steps: sample acquiring: acquiring a nasal endoscope image, wherein the nasal endoscope image comprises a nasopharyngeal carcinoma group and a non-nasopharyngeal carcinoma group; preprocessing: preprocessing the nasal endoscope image; and model training: inputting the preprocessed nasal endoscope image into a convolutional neural network, and training the convolutional neural network to obtain a nasopharyngeal carcinoma auxiliary diagnosis model. According to the invention, the nasopharyngeal endoscope image can be analyzed, and the predicted illness probability is output in real time to assist a doctor in nasopharyngeal carcinoma diagnosis, so that the accuracy of nasopharyngeal carcinoma diagnosis can beeffectively improved, and the biopsy detection rate is increased so as to achieve the purposes of early screening, early diagnosis and early treatment of nasopharyngeal carcinoma and improvement of treatment effect and prognosis of patients.
Owner:THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1

Method for building candidate marker diagnosis model for OA (osteoarthritis)

InactiveCN107727729AMaterial analysis by electric/magnetic meansDiagnosis earlyDisease
The invention discloses a method for building a candidate marker diagnosis model for OA (osteoarthritis). The method comprises the following steps: (1) building an STR / ort model mice serum, and contrasting mice serums; (2) finding and discovering serum difference expression through combination of iTRAQ marks and MALDI-TOF MS / MS; (3) analyzing and screening candidate marker protein through bioinformatics; (4) verifying OA candidate marker protein; (5) detecting candidate markers in serums of patients and analyzing relation between the candidate markers and OA disease courses; (6) establishing amethod for building the candidate marker diagnosis model for OA. According to the method disclosed by the invention, markers are confirmed through samples of population, values for diagnosing OA by the OA candidate markers are evaluated and correlation between the candidate marker diagnosis model and clinics is analyzed, and the feasibility of the candidate marker diagnosis model on clinical application such as prevention and early diagnosis to OA and a meaning of the candidate marker diagnosis model in health alarm of OA of the population are proposed.
Owner:NANNING KECHENGHUI INFORMATION TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products